Abstract |
Ten cases of antibiotic-associated pseudomembranous colitis in children are reviewed. The ages ranged from 4 years to 17 years; the most frequently implicated antimicrobial agents were penicillins in six children and clindamycin in two. Stool assays showed specimens from all ten patients yielded a cytopathic toxin which was neutralized by Clostridium sordellii antitoxin with titers ranging from 1:40 to 1:40,000. Bacterial cultures of nine specimens uniformly yielded Clostridium difficile with a median concentration of 10(5.4) organisms per gram of wet weight. All nine isolates of C difficile showed a vitro production of a cytopathic toxin which was similar to or identical with that which was detected in the original stool specimen. All ten patients recovered. Six were treated with oral vancomycin and showed a good therapeutic response; one patient, however, suffered two relapses when treatment was discontinued, requiring a total of three courses of oral vancomycin. Two patients received cholestyramine and responded well. These observations provide supportive evidence that C difficile is responsible for antibiotic-associated pseudomembranous colitis in children and document efficacy of the newer therapeutic modalities in this patient population as well.
|
Authors | R P Viscidi, J G Bartlett |
Journal | Pediatrics
(Pediatrics)
Vol. 67
Issue 3
Pg. 381-6
(Mar 1981)
ISSN: 0031-4005 [Print] United States |
PMID | 7243476
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Bacterial Agents
- Cholestyramine Resin
- Clindamycin
- Vancomycin
- Ampicillin
- Penicillin G
|
Topics |
- Administration, Oral
- Adolescent
- Ampicillin
(adverse effects)
- Anti-Bacterial Agents
(adverse effects)
- Child
- Child, Preschool
- Cholestyramine Resin
(therapeutic use)
- Clindamycin
(adverse effects)
- Clostridium
(isolation & purification)
- Clostridium Infections
(complications)
- Enterocolitis, Pseudomembranous
(chemically induced, drug therapy, etiology)
- Feces
(analysis)
- Female
- Humans
- Infant
- Male
- Penicillin G
(adverse effects)
- Vancomycin
(therapeutic use)
|